The output of basic pharmaceutical products and pharmaceutical preparations in Poland has exhibited varied trends over the past decade. Actual data shows that the market fluctuated between highs of 3.99 billion euros in 2017 and lows of 3.38 billion euros in 2019. Despite these fluctuations, the average growth rate per year over the last 5 years stands at 3%. In 2023, the output reached 3.93 billion euros with a year-on-year variation of 2.25%.

The forecasts from 2024 indicate a steady increase in output, projecting a value of 4.35 billion euros by 2028, with an average annual growth rate of 1.61% over the next 5 years. This suggests gradual but consistent expansion in Poland's pharmaceutical sector.

Future trends to watch for:

Innovations in pharmaceutical technologies and their impact on production capacities.
Regulatory changes in Poland and the broader EU market which might affect pharmaceutical output.
Potential shifts in global supply chains due to geopolitical factors.
Increased focus on health security and pandemic preparedness.
Emerging markets and their demand for Polish pharmaceutical products.